Characteristics of primary biliary cirrhosis in British Columbia's First Nations population

Canadian Journal of Gastroenterology

Volumn 19, Issue 5, 2005, Pages 305-310

  Arbour, Laura ^a   Rupps, Rosemarie ^a   Field, Leigh ^a   Ross, Paul ^b   Erikson, Anders ^c   Henderson, Harvey ^d   Hill, Warren ^a   Yoshida, Eric M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b British Columbia Transplant Society   (Canada)

^c VICTORIA GENERAL HOSPITAL   (Canada)

^d University of Bristish Columbia ^*

Author keywords

American Indians; Autoimmune liver disease; First Nations; Genetic predisposition; Primary biliary cirrhosis; Recurrence risk

Indexed keywords

MITOCHONDRION ANTIBODY;

ADULT; AGE; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CANADA; CLINICAL ARTICLE; CLINICAL STUDY; COMORBIDITY; DATA ANALYSIS; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; MEDICAL RECORD; PATIENT REFERRAL; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECURRENCE RISK; RELATIVE; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE; TOPOGRAPHY;

EID: 20444477923     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/203028     Document Type: Article

References (41)

1. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570-80.
2. Poupon RE, Bonnand AM, Chretien Y, Poupon R. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group. Hepatology 1999;29:1668-71.
3. Pares A, Caballeria L, Rodes J, et al. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: Results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver. J Hepatol 2000;32:561-6.
4. Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 1995;36:615-7.
5. Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol 1994;20:698-701.
6. Caldwell SH, Leung PS, Spivey JR, et al. Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: Antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members. Hepatology 1992;16:899-905.
7. Borum ML. Hepatobiliary diseases in women. Med Clin North Am 1998;82:51-75.
8. Mayo MJ. Primary biliary cirrhosis: The future. Clin Liver Dis 2003;7:957-69.
9. Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Familial primary biliary cirrhosis reassessed: A geographically-based population study. J Hepatol 1999;30:402-7.
10. Gershwin ME, Leung PS, Li H, Seldin MF. Primary biliary cirrhosis and autoimmunity: Evaluating the genetic risk. Isr Med Assoc J 2000;2(Suppl):7-10.
11. Gordon MA, Oppenheim E, Camp NJ, di Giovine FS, Duff GW, Gleeson D. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. J Hepatol 1999;31:242-7.
12. Agarwal K, Jones DE, Daly AK, et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000;32:538-41.
13. Matsushita M, Miyakawa H, Tanaka A, et al. Single nucleotide polymorphisms of the mannose-binding lectin are associated with susceptibility to primary biliary cirrhosis. J Autoimmun 2001;17:251-7.
14. Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2002;35:126-31.
15. Corpechot C, Benlian P, Barbu V, Chazouilleres O, Poupon RE, Poupon R. Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis? J Hepatol 2001;35:324-8.
16. Jones DE, Donaldson PT. Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin Liver Dis 2003;7:841-64.
17. Wadstrom T, Ljungh A, Willen R. Primary biliary cirrhosis and primary sclerosing cholangitis are of infectious origin! Gut 2001;49:454.
18. Xu L, Shen Z, Guo L, et al. Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci 2003;100:8454-9.
19. Mason A. Viral induction of type 2 diabetes and autoimmune liver disease. J Nutr 2001;131:2805S-2808S.
20. Martin JD, Yidegiligne HM. Diabetes mellitus in the First Nations population of British Columbia. Int J Circumpolar Health 1998;57(Suppl 1):335-9.
21. Hill W, Mak S, Descantes C, Engwer L, Krajden M. Geographic Information Systems (GIS) for policy development and planning of hepatitis C (HCV) virus prevention and care in British Columbia: Frontiers in Viral Hepatitis," Kapalua, Maui, Hawaii, Dec 16-20, 2001. (Abst)
22. Statistics Canada 2001 census profile. http://www.bcstats.gov.bc.ca/data/cen01/profiles/59000000.pdf. (Version current at April 5, 2005).
23. Yoshida EM, Caron NR, Buczkowski AK, et al. Indications for liver transplantation in British Columbia's Aboriginal population: A ten-year retrospective analysis. Can J Gastroenterol 2000;14:775-9.
24. Arbour L, Field L, Ross P, Erikson A, Yoshida E. The mystery of primary biliary cirrhosis in British Columbia's First Nations people. Int J Circumpolar Health 2004;63(Suppl 2):185-8.
25. Farrer LA, Cupples LA. Determining the genetic component of a disease. In: Haines J, Pericak-Vance MA, eds. Approaches to Gene Mapping in Complex Human Diseases. New York: Wiley-Liss, 1998:93-130.
26. Atkins C, Reuffel L, Roddy J, Platts M, Robinson H, Ward R. Rheumatic disease in the Nuu-Chah-Nulth native Indians of the Pacific Northwest. J Rheumatol 1988;15:684-90.
27. Boyer GS, Templin DW, Lanier AP. Rheumatic diseases in Alaskan Indians of the southeast coast: High prevalence of rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 1991;18:1477-84.
28. Peschken CA, Esdaile JM. Systemic lupus erythematosus in North American Indians: A population based study. J Rheumatol 2000;27:1884-91.
29. Peschken CA, Esdaile JM. Rheumatic diseases in North America's indigenous peoples. Semin Arthritis Rheum 1999;28:368-91.
30. Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol 2002;97:2402-7.
31. British Columbia Vital Statistics Agency. Regional analysis of health statistics for status Indians in British Columbia, 1992-2002. http://www.vs.gov.bc.ca/stats/indian/index.html (Version current at April 11, 2005).
32. Heathcote J. The clinical expression of primary biliary cirrhosis. Semin Liver Dis 1997;17:23-33.
33. Laurin JM, DeSotel CK, Jorgensen RA, Dickson ER, Lindor KD. The natural history of abdominal pain associated with primary biliary cirrhosis. Am J Gastroenterol 1994;89:1840-3.
34. Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003;362:53-61.
35. Tokuhiro S, Yamada R, Chang X, et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003;35:341-8.
36. Prokunina, Castillejo-Lopez C, Oberg F, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002;32:666-9.
37. Poupon R. Autoimmune overlapping syndromes. Clin Liver Dis 2003;7:865-78.
38. Leung PS, Coppel RL, Ansari A, Munoz S, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis 1997;17:61-9.
39. Chagnon P, Michaud J, Mitchell G, et al. A missense mutation (R565W) in cirhin (FLJ14728) in North America Indian childhood cirrhosis. Am J Hum Genet 2002;71:1443-9.
40. Klomp LW, Bull LN, Knisely AS, et al. A missense mutation in FICI is associated with greenland familial cholestasis. Hepatology 2000;32:1337-41.
41. Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Familial primary biliary cirrhosis reassessed: A geographically based population study. J Hepatol 1999;30:402-407.